Efficacy and safety of mono antiplatelet therapy with colchicine in acute coronary syndrome patients following percutaneous coronary intervention: rationale and design of the MACT II trial

IntroductionEarly discontinuation of aspirin after percutaneous coronary intervention (PCI) reduces bleeding risk, while inflammation-targeted strategies may offer additional benefit in patients with acute coronary syndrome (ACS). Residual inflammatory risk—reflected by persistently elevated high-se...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Ji Yong Jang, Yongsung Suh, Choongki Kim, Jeong Tae Byoun, Kyeong Ho Yun, Jung-Hee Lee, Ki-Hyun Jeon, Sungsoo Cho, Hyuk-Joon Yoon, Jin Won Kim, Bom Lee, Se Hun Kang, Sang-Hoon Kim, Jae Youn Moon, Yangsoo Jang, Seung-Yul Lee
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2025-10-01
Rangatū:	Frontiers in Cardiovascular Medicine
Ngā marau:	acute coronary syndrome percutaneous coronary intervention aspirin colchicine ticagrelor
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1662392/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!